Grifols Bio Supplies Inc — FDA Facility Profile

FEI 3000719222

Grifols Bio Supplies Inc is an FDA-inspected facility (FEI 3000719222) located in Philadelphia, PA, US. RegDataLab tracks 8 FDA inspections at this facility.

Reviewing Grifols Bio Supplies Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Grifols Bio Supplies Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Aug 13, 2024: No Action Indicated (NAI)
Inspections on record
8 (5 VAI, 3 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Aug 13, 2024No Action Indicated (NAI)No citations listed
Nov 8, 2019No Action Indicated (NAI)No citations listed
Dec 13, 2016Voluntary Action Indicated (VAI)Cumulative deferral record HTLV, Chagas (21 CFR 606.160(e)(2))
Test for HTLV, syphilis, West Nile, Chagas (21 CFR 610.40(a)(2))
Additional Medical Assessment Factors (21 CFR 630.10(e)(2))
Proof Of Identity (21 CFR 630.10(g)(1))
and 1 more
Feb 20, 2015Voluntary Action Indicated (VAI)Notification (21 CFR 630.40(a))
Mar 12, 2013Voluntary Action Indicated (VAI)Same as for whole blood (21 CFR 660.32)
Thorough investigations (21 CFR 606.100(c))
Apr 11, 2012No Action Indicated (NAI)No citations listed
Dec 22, 2010Voluntary Action Indicated (VAI)Donor suitability procedures not followed (21 CFR 640.3(a)(1))
Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b))
Notification (21 CFR 630.40(a))
Same as for whole blood (21 CFR 660.32)
and 1 more
Mar 3, 2009Voluntary Action Indicated (VAI)Same as for whole blood donor (21 CFR 660.31)
Same as for whole blood (21 CFR 660.32)

Facility details

Company
Grifols Bio Supplies Inc
Location
Philadelphia, PA (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.